Alan James Cox

Touch Bionics Ltd. provides prosthetic technologies and supporting services for the people with upper limb deficiencies. Its products develop upper-limb prosthetic technologies and specializes in myoelectronic hand and partial hand solutions, as well as a realistic silicone prostheses that are designed to closely match the skin of the wearer. Touch Bionics was founded in 2003 by David Gow and is headquartered in Livingston, the United Kingdom.

Noble Grossart Ltd. provides banking services. It focuses on the provision of strategic financial advice to allow company boards, shareholders, and financial institutions to achieve their corporate objectives. The firm's services include mergers and acquisitions, company valuation, equity fundraising, disposals, application of the UK takeover code, debt raising and structuring, strategic financial advice, creating internal share trading arrangements, capital restructuring. The company was founded in 1969 and is headquartered in Edinburgh, the United Kingdom.

CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom.

Archangel Investors Ltd. is a Private Equity firm, a subsidiary of Riverside Global Partners LLC founded in 1988 by Michael David Rutterford and Barry Edward Sealey. The firm is headquartered in Boston.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom.

NCTech Ltd. designs and manufactures cameras. It develops automatic instant 360? panoramic camera. The iSTAR represents technical advances in high resolution digital imaging, positioning new standards in ease of use, speed, image quality and image resolution allowing for multiple fields of application. It offers engineering, immersive media, case studies, and application notes solutions. The company was founded by Neil Tocher and Cameron James Ure in 2010 and is headquartered in Edinburgh, the United Kingdom.